Form EFFECT Silence Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 27, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jaguar Uranium Reports Preliminary Surface Sampling Results from Huemul Uranium-Copper-Vanadium Project
- Kraken Robotics Announces $35 Million in New Orders and Business Update
- Loganair Adds BETA Technologies ALIA CTOL Aircraft to Its Fleet, Following Successful Demonstrations in United Kingdom
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share